HAPLOGEN GENOMICS GMBH
HAPLOGEN GENOMICS GMBH
Industry:
Biotechnology Health Care
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.haplogen.at
Status:
Active
Contact:
43-1-916-5522
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Key Systems DNS Key-Systems
More informations about "Haplogen Genomics GmbH"
HAPLOGEN Bioscience GmbH - Life Sciences Directory
Organization type RDM biotech/pharma Region Vienna Cluster LISAvienna Focus human health / animal health Profile. Haplogen, founded 2010 is a Vienna based, privately owned …See details»
Haplogen Company Profile | Management and Employees List
Haplogen Profile and History Haplogen is a privately held biotechnology company in Vienna, Austria, with drug discovery programs to combat viral infectious and other diseases. …See details»
Haplogen - Lab Manager
Aug 26, 2013 Organization profile for Haplogen on Lab Manager. Haplogen, a biotechnology company developing antiviral therapies, and CeMM, the Center for Molecular Medicine of the …See details»
Haplogen GmbH - Wien, Austria - bionity.com
Haplogen GmbH is a privately held biotechnology company with an entirely novel target identification technology based on human haploid genetics and a drug discovery pipeline in …See details»
HAPLOGEN GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for HAPLOGEN GmbH of Wien, Wien. Get the latest business insights from Dun & Bradstreet.See details»
haplogen: Cyclenium Pharma and Haplogen Announce Drug …
May 7, 2015 Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the research and development of novel drug candidates based on its proprietary macrocyclic …See details»
Haplogen Company Profile - Office Locations, Competitors ... - Craft
Haplogen is a biopharmaceutical company that focuses on therapeutic programs in the area of virus-caused diseases. It aims to promote human health using its genetics technology platform …See details»
Haplogen Gmbh - Crunchbase Company Profile & Funding
Organization. Haplogen Gmbh . Connect to CRM . Save . Summary. People. Signals & News. ... Haplogen is a privately held biotechnology firm based on an innovative genetic technology …See details»
Cyclenium Pharma and Haplogen Bioscience Announce Granting …
Commercialization of innovative Canadian technologies, while Haplogen Bioscience has been awarded a grant from the Austrian Research Promotion Agency (FFG), the country’s national …See details»
Haplogen - Products, Competitors, Financials, Employees, …
Haplogen GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12092018 Prices from USD $250. Nov 10, 2018. Summary Haplogen GmbH Haplogen is a …See details»
Haplogen Genomics GmbH - Crunchbase Company Profile
Haplogen Genomics GmbH is located in Vienna, Wien, Austria. Who are Haplogen Genomics GmbH 's competitors? Alternatives and possible competitors to Haplogen Genomics GmbH …See details»
Life Sciences Directory: HAPLOGEN Bioscience GmbH
Organization type RDM biotech/pharma Region Vienna Cluster LISAvienna Focus human health / animal health Profile. Haplogen, founded 2010 is a Vienna based, privately owned …See details»
Haplogen GmbH - BioCentury Company Profiles - BCIQ
Jan 18, 2017 Haplogen GmbH - BioCentury Company Profiles for the biopharma industrySee details»
Haplogen - CeMM
Haplogen (current) MyeloPro; Aelian Biotechnology; Haplogen is a biopharmaceutical company with the mission to improve human health by combating infectious disease. Employing a …See details»
Haplogen - Overview, News & Similar companies | ZoomInfo.com
Haplogen's therapeutic programs are based on novel mechanisms that have been discovered using a functional genomics platform based on haploid genetics in human cell lines. Haplogen …See details»
HAPLOGEN ENTERS INTO A COLLABORATION WITH BAYER
Haplogen is a privately held biotechnology company in Vienna, Austria, with drug discovery programs to combat viral infections and other diseases. Haplogen’s therapeutic programs are …See details»
Horizon Discovery acquires the CeMM spin out company …
Jan 8, 2015 Today it was announced that the UK life science company Horizon Discovery Group plc acquired Haplogen Genomics GmbH, a wholly subsidiary of Haplogen GmbH, the first …See details»
CeMM and Haplogen make available the world’s largest collection …
Aug 26, 2013 The partnership, through Haplogen, will distribute requested cell lines to the research community. The collection and the technological advances that enabled its …See details»
Haplogen: Horizon Discovery Signs Distribution Agreement with …
Feb 12, 2014 Haplogen’s Haploid Gene Trap Mutant Collection is the largest haploid cell line bank available, and comprises over 9,400 mutant clones, affecting over 3,700 human genes …See details»
Evotec partners with Haplogen to develop drugs for infectious …
Hamburg, Germany, Vienna, Austria - 15 November 2012: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) and Haplogen GmbH have signed a collaboration agreement to discover and …See details»